Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
Reproductive Empowerment and Support Through Optimal Restoration Act or the RESTORE ACT This bill explicitly prohibits penalizing health care providers for declining to participate in assisted reproductive technology (e.g., in vitro fertilization). It also modifies services and training relating to reproductive health, especially to support an approach the bill refers to as restorative reproductive medicine . The bill describes restorative reproductive medicine as using methods such as monitoring reproductive health and addressing health conditions that may cause infertility (e.g., endometriosis) to restore reproductive function without using methods such as assisted reproductive technology. The bill prohibits the federal government and entities receiving federal funding from penalizing health care providers that decline to (1) participate in assisted reproductive technology, or (2) facilitate such activities due to religious beliefs or moral convictions. The Department of Health and Human Services (HHS) must update the medical codes for classifying infertility treatments to reflect the latest practices for restorative reproductive medicine. Also, HHS must expand the Teen Pregnancy Prevention program to include grants to entities focusing on restorative reproductive medicine. HHS must also deem entities providing or teaching restorative reproductive medicine eligible for certain family planning grants, when otherwise eligible. Additionally, HHS must issue reports every three years on the standards of care for diagnosing infertility and reproductive health conditions, require the Reproductive Health National Training Center to provide training on restorative reproductive medicine, develop education within HHS programs on treating male infertility, and expand research on restorative reproductive medicine and reproductive health conditions.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2026 · third_quarter · Copyright/Patent/Trademark
Patent litigation issues. H.R.1109 - Litigation Transparency Act of 2025. H.R.2675/S.3180 - Protecting Our Courts from Foreign Manipulation Act of 2025. H.R.3589/S.1882 - RESTORE Act. Third party litigation funding disclosure issues.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
General issues related to access to fertility treatments, including in H.R.1670/S.97, the Family Building FEHB Fairness Act, H.R.2049, the Access to Family Building Act, S.1882/H.R.3589, the RESTORE Act, S.2035, the Protect IVF Act, H.R.7040/S.3101, the SAFE KIDS Act, H.R.8119, the HOPE with Fertility Services Act, and H.R.9941/S.5108, the Right to IVF Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Copyright/Patent/Trademark
Patent litigation issues. H.R.1109 - Litigation Transparency Act of 2025. H.R.2675/S.3180 - Protecting Our Courts from Foreign Manipulation Act of 2025. H.R.3589/S.1882 - RESTORE Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
General issues related to access to fertility treatments, including in H.R.1670/S.97, the Family Building FEHB Fairness Act, H.R.2049, the Access to Family Building Act, S.1882/H.R.3589, the RESTORE Act, S.2035, the Protect IVF Act, H.R.7040/S.3101, the SAFE KIDS Act, and H.R.8119, the HOPE with Fertility Services Act
Client expense: Not reported · Firm income: $20,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Health Issues
General issues related to access to fertility treatments, including in H.R.1670/S.97, the Family Building FEHB Fairness Act, H.R.2049, the Access to Family Building Act, S.1882/H.R.3589, the RESTORE Act, S.2035, the Protect IVF Act, H.R.7040/S.3101, the SAFE KIDS Act, and H.R.8119, the HOPE with Fertility Services Act
Client expense: Not reported · Firm income: $20,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · fourth_quarter · Health Issues
General issues related to access to fertility treatments, including in H.R.1670/S.97, the Family Building FEHB Fairness Act, H.R.2049, the Access to Family Building Act, S.1882/H.R.3589, the RESTORE Act, and S.2035, the Protect IVF Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Family issues/Abortion/Adoption
H.R. 1 One Big Beautiful Bill Act; H.R.2557 IVF For Military Families Act; S.2035 Protect IVF Act; S.1882, H.R.3589 RESTORE Act; Shield laws; Chemical abortion drugs; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; H.R. 5485 Second Chance at Life Act of 2025; S.2418 HEALING Mothers and Fathers Act; S.2433 Neonatal Care Transparency Act of 2025; H.Res.611 Expressing the importance of accurate information for medical professionals treating pregnant women and their unborn children in the emergency department, and for informing the general public, and for other purposes; S.2955 A bill to amend title 18, United States Code, to establish Federal penalties for the knowing and intentional administration of any abortion-inducing drug to a woman without her informed consent, if the abortion-inducing drug has been shipped or transported in interstate commerce, and for other purposes; Patient Protection and Affordable Care Act; Abortion funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S. 5371 Continuing Appropriations and Extensions Act, 2026; Contraception issues; IVF issues; National Defense Authorization Act; Supreme Court Decisions; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Client expense: $360,000 · Firm income: Not reported
2025 · third_quarter · Health Issues
H.R. 1 One Big Beautiful Bill Act; S.1882, H.R.3589 RESTORE Act; Shield Laws; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; S.2418 HEALING Mothers and Fathers Act; S.2433 Neonatal Care Transparency Act of 2025; H.Res.611 Expressing the importance of accurate information for medical professionals treating pregnant women and their unborn children in the emergency department, and for informing the general public, and for other purposes; Patient Protection and Affordable Care Act; Contraception Issues; National Defense Authorization Act; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Client expense: $360,000 · Firm income: Not reported
2025 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 1 One Big Beautiful Bill Act; S.1882, H.R.3589 RESTORE Act; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; H.R.2075, S.987 Protecting Life and Integrity in Research Act of 2025; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; H.R. 685 Support and Value Expectant Moms and Babies Act; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; IVF Issues; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Client expense: $360,000 · Firm income: Not reported
2025 · third_quarter · Health Issues
General issues related to access to fertility treatments, including in H.R.1670/S.97, the Family Building FEHB Fairness Act, H.R.2049, the Access to Family Building Act, S.1882/H.R.3589, the RESTORE Act, and S.2035, the Protect IVF Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Family issues/Abortion/Adoption
H.R. 1 One Big Beautiful Bill Act; S.1756, H.R.3411 Conscience Protection Act; H.R.2557 IVF For Military Families Act; S.2035 Protect IVF Act; S.1882, H.R.3589 RESTORE Act; S.J.Res. 56, H.J.Res.98 Life Month; H.R.3287 Pregnancy.Gov Act; S.1384, H.R. 2779 Abortion Funding Awareness Act; H.R. 2706 Aid Accountability Act of 2025; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; S.1834, H.R.3762 Supporting Healthy Moms and Babies Act; H.R. 589, S. 223 FACE Act Repeal of 2025; H.R.2075, S.987 Protecting Life and Integrity in Research Act of 2025; H.R.21, S. 6 Born-Alive Abortion Survivors Protection Act; Shield Laws; H.R. 1104, S. 230 Unborn Child Support; Unborn Child Tax Credit; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; S.2150, H.R. 12 Womens Health Protection Act; H.R. 685 Support and Value Expectant Moms and Babies Act; Chemical abortion drugs; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; Supporting Pregnant and Parenting Women and Families Act; S.178, H.R.627 Ensuring Accurate and Complete Abortion Data Reporting Act of 2025; Abortion Funding; Contraception Issues; IVF Issues; H.R. 353, S.1382 Family First Act; National Defense Authorization Act; H.R.271 Defund Planned Parenthood Act; S. 203 Defund Planned Parenthood Act; Supreme Court Decisions; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631 Restoring Safeguards for Dangerous Abortion Drugs Act; S.242 Dignity for Aborted Children Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
2025 · second_quarter · Health Issues
H.R. 1 One Big Beautiful Bill Act; S.1756, H.R.3411 Conscience Protection Act; S.1882, H.R.3589 RESTORE Act; H.R.3287 Pregnancy.Gov Act; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; S.1834, H.R.3762 Supporting Healthy Moms and Babies Act; H.R. 589, S. 223 FACE Act Repeal of 2025; H.R.21, S. 6 Born-Alive Abortion Survivors Protection Act; Shield Laws; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; S.2150, H.R. 12 Womens Health Protection Act; H.R. 685 Support and Value Expectant Moms and Babies Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; S.178, H.R.627 Ensuring Accurate and Complete Abortion Data Reporting Act of 2025; Contraception Issues; National Defense Authorization Act; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S.242 Dignity for Aborted Children Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Client expense: $490,000 · Firm income: Not reported
2025 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 1 One Big Beautiful Bill Act; S.1882, H.R.3589 RESTORE Act; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; H.R.2075, S.987 Protecting Life and Integrity in Research Act of 2025; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; H.R. 685 Support and Value Expectant Moms and Babies Act; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; IVF Issues; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Client expense: $490,000 · Firm income: Not reported
2025 · second_quarter · Health Issues
S 1882 / HR 3589 "RESTORE Act," all provisions.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| AK |
| Riley M. Moore | Republican | WV |
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Client expense: $490,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office